Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Capital One Financial
COF
5
Citigroup
C
AU Stock MarketDetailed Quotes
MDC Medlab Clinical Ltd
- 6.900
- 0.0000.00%
20min DelayNot Open Mar 3 10:00 AET
15.76MMarket Cap-7.42P/E (Static)
0.000High0.000Low0Volume0.000Open6.900Pre Close0.00Turnover0.00052wk High0.00%Turnover Ratio2.28MShares0.00052wk Low-0.93EPS TTM10.70MFloat Cap0.000Historical HighLossP/E (Static)1.55MShs Float0.000Historical Low-0.93EPS LYR0.00%Amplitude--Dividend TTM1.95P/B1Lot Size--Div YieldTTM
About Medlab Clinical Ltd Company
Medlab Clinical Ltd is an Australian biotechnology company that specializes in the application of NanoCelle drug delivery technology to existing and new pharmaceuticals to empower patients with chronic diseases and mental health conditions and enhance their lives.. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B, and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.
Company Profile
SymbolMDC
Company NameMedlab Clinical Ltd
Founded2014
MarketASX
Fiscal Year Ends06-30
Address50 Kings Park Road Level 2
CityWest Perth
CountryAustralia
Zip Code6005
Phone+61 281880311
Websitehttps://www.medlab.co
Share Registry--
Company Executives
- Name
- Position
- Salary
- Tim Walker
- Non-Executive Director
- --
- Matthew John Hudson
- Non-Executive Director
- --
- Edmond Tan
- Non-Executive Director
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting